CURADERM
Live / Allowed — Published for opposition (as of 01 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79433015
- Mark type
- Word mark
- Filed
- 25 Aug 2025
- Published for opposition
- 01 Sept 2026
- Attorney of record
- Douglas M. McAllister
Goods and services
- Class 001 — Chemicals: Chemical products for industrial and scientific purposes, namely chemical products as active ingredients for use in the manufacture of food products; gelatine glue for industrial purposes; protein in raw material form, in particular for industrial and scientific research purposes and for use in the manufacture of foodstuffs, luxury foodstuffs and beverages, chemical, pharmaceutical, cosmetic and veterinary products and preparations, dietetic products and food supplements; protein in the form of raw material, in particular collagen peptides for scientific purposes; gelatine being raw material, in particular for industrial purposes and for use in the manufacture of foodstuffs and beverages, pharmaceutical, cosmetic and veterinary products, dietetic products and food supplements; gelatine hydrolysate in raw material form, in particular for industrial purposes and for use in the manufacture of foodstuffs and beverages, pharmaceutical, cosmetic and veterinary products, dietetic products and food supplements; collagen in the form of raw material and collagen fibers, in particular for industrial purposes and for use in the manufacture of foodstuffs and beverages, pharmaceutical, cosmetic and veterinary products; collagen hydrolysate being raw material, in particular for industrial purposes and for use in the manufacture of foodstuffs and beverages, pharmaceutical, cosmetic and veterinary products; proteins, in particular collagen peptides, for use in the manufacture of foodstuffs; proteins in raw material form, in particular collagen peptides, for human and animal consumption; proteins, in particular collagen peptides, for human consumption; proteins for human consumption, which form emulsions in the manufacturing process; proteins, in particular collagen peptides, for use in science; protein products in the form of raw material; proteins, in particular collagen peptides, for use in manufacture; proteins for use in the manufacture of beverages; proteins in the form of raw materials, in particular collagen peptides, for use in the manufacture of sports nutrition beverages, athlete nutrition supplements, nutritional supplements for sports and nutritional supplements for athletes in solid, liquid or powder form; proteins, in particular collagen peptides, for use in the manufacture of foods for animals and animal feed; chemical preparations for use as animal feed supplements; proteins, in particular gelatine and gelatine hydrolysate, for use in the manufacture of foods for animals, animal feed supplements and veterinary products and preparations; proteins in the form of raw materials, in particular collagen peptides, for use in the manufacture of food supplements for humans and animals; proteins, in particular collagen peptides, for non-medicinal purposes for use in gene technology; proteins in the form of raw material for use in the manufacture of medicines and pharmaceuticals and preparations for use in the treatment of mental illnesses, for use in wound healing and for use in the treatment of skin diseases; proteins and protein mixtures for industrial and scientific purposes; proteins and protein-containing products in solid, liquid or dissolved form as raw products for use in the preparation of food, for use in the manufacture of pharmaceutical and veterinary products, dietetic products, cosmetic products, for technical purposes and for use in the manufacture of feedstuffs; animal and vegetable proteins in solid or liquid form for industrial or technical purposes; animal and vegetable proteins, fats and oils in solid or liquid form for use in the manufacture of pharmaceuticals
Owner
Prosecution history
- 01 Sept 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Sept 2026 — PUBLISHED FOR OPPOSITION
- 26 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Jul 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 28 Jul 2026 — EXAMINER'S AMENDMENT ENTERED
- 28 Jul 2026 — EXAMINERS AMENDMENT E-MAILED
- 28 Jul 2026 — EXAMINERS AMENDMENT -WRITTEN
- 26 Feb 2026 — REFUSAL PROCESSED BY IB
- 10 Feb 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 10 Feb 2026 — REFUSAL PROCESSED BY MPU
- 15 Jan 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 14 Jan 2026 — NON-FINAL ACTION WRITTEN
- 08 Jan 2026 — ASSIGNED TO EXAMINER
- 22 Sept 2025 — APPLICATION FILING RECEIPT MAILED